Braun Stacey Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-20,325
| Closed | -$1.59M | – | 117 |
|
2024
Q2 | $1.59M | Sell |
20,325
-47,503
| -70% | -$3.71M | 0.06% | 93 |
|
2024
Q1 | $4.6M | Sell |
67,828
-43,676
| -39% | -$2.96M | 0.18% | 89 |
|
2023
Q4 | $7.51M | Sell |
111,504
-28,590
| -20% | -$1.93M | 0.34% | 88 |
|
2023
Q3 | $9.49M | Sell |
140,094
-35,305
| -20% | -$2.39M | 0.46% | 84 |
|
2023
Q2 | $12.6M | Sell |
175,399
-150,879
| -46% | -$10.8M | 0.58% | 82 |
|
2023
Q1 | $22.6M | Buy |
326,278
+184,006
| +129% | +$12.8M | 0.59% | 84 |
|
2022
Q4 | $9.65M | Sell |
142,272
-24,786
| -15% | -$1.68M | 0.55% | 83 |
|
2022
Q3 | $9.16M | Sell |
167,058
-37,955
| -19% | -$2.08M | 0.56% | 84 |
|
2022
Q2 | $13.5M | Buy |
+205,013
| New | +$13.5M | 0.77% | 61 |
|
2017
Q1 | – | Sell |
-9,100
| Closed | -$249K | – | 142 |
|
2016
Q4 | $249K | Sell |
9,100
-4,000
| -31% | -$109K | 0.02% | 150 |
|
2016
Q3 | $430K | Hold |
13,100
| – | – | 0.03% | 129 |
|
2016
Q2 | $395K | Hold |
13,100
| – | – | 0.03% | 132 |
|
2016
Q1 | $369K | Hold |
13,100
| – | – | 0.02% | 136 |
|
2015
Q4 | $445K | Hold |
13,100
| – | – | 0.03% | 122 |
|
2015
Q3 | $417K | Sell |
13,100
-22,900
| -64% | -$729K | 0.03% | 122 |
|
2015
Q2 | $573K | Buy |
36,000
+20,800
| +137% | +$331K | 0.02% | 226 |
|
2015
Q1 | $520K | Buy |
15,200
+5,800
| +62% | +$198K | 0.03% | 115 |
|
2014
Q4 | $331K | Hold |
9,400
| – | – | 0.02% | 135 |
|
2014
Q3 | $336K | Sell |
9,400
-600
| -6% | -$21.4K | 0.02% | 133 |
|
2014
Q2 | $372K | Sell |
10,000
-2,000
| -17% | -$74.4K | 0.02% | 125 |
|
2014
Q1 | $389K | Hold |
12,000
| – | – | 0.02% | 121 |
|
2013
Q4 | $356K | Hold |
12,000
| – | – | 0.02% | 121 |
|
2013
Q3 | $312K | Hold |
12,000
| – | – | 0.02% | 123 |
|
2013
Q2 | $284K | Buy |
+12,000
| New | +$284K | 0.02% | 134 |
|